Home › Funds › Vivo Capital, LLC › ODTX

Vivo Capital, LLC position in ODTX

Odyssey Therapeutics Inc · Health Care

Vivo Capital, LLC reported holding 575,000 shares of ODTX (Odyssey Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$12.8M, representing 1.45% of its reported portfolio and ranking #23 among its reported holdings. Vivo Capital, LLC has disclosed ODTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)575.00K sh
Reported value held$12.78M
Portfolio Weight1.45%
First reportedQ2 2026
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's ODTX position evolved

Vivo Capital, LLC first disclosed a stake in ODTX in Q2 2026 at 575,000 shares (US$10.8M). The position peaked in Q3 2026 at 575,000 shares, worth US$12.8M. Across 2 filings, Vivo Capital, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 575,000 shares valued at US$12.8M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 575.00K $10.76M New
Q3 2026 575.00K $12.78M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ODTX and 13F data

ODTX (Odyssey Therapeutics Inc) is a Health Care company. 76 other funds we track also report a position in ODTX — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$71.0M), TPG GP A, LLC (US$69.0M), Lightspeed Management Company, L.L.C. (US$67.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ODTX

All ODTX fund holders →

FAQ

How long has Vivo Capital, LLC held ODTX?

Vivo Capital, LLC has disclosed ODTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Vivo Capital, LLC's current position in ODTX?

As of Q3 2026, Vivo Capital, LLC holds 575.00K shares of ODTX (Odyssey Therapeutics Inc), valued at $12.78M, representing 1.45% of its reported portfolio and ranking #23.

Has Vivo Capital, LLC been buying or selling ODTX?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in ODTX. The position peaked in Q3 2026 at 575.00K shares.

Which other funds hold ODTX?

Other major institutional holders of ODTX include SR ONE CAPITAL MANAGEMENT, LP, TPG GP A, LLC, Lightspeed Management Company, L.L.C., among 76 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.